Investor Alert

New York Markets Close in:

Denali Therapeutics Inc.



Countdown to close

 --Real time quotes

Mar 24, 2023, 3:14 p.m.





-0.15 -0.65%


Volume 375,039

Real time quotes


Previous close

$ 22.91

$ 22.76


-0.15 -0.65%

Day low

Day high




52 week low

52 week high




Annual Financials for Denali Therapeutics Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Net Income before Extraordinaries (36.24M)(197.61M)71.14M(290.58M)(325.99M)
Depreciation, Depletion & Amortization 7.42M7.99M6.17M5.61M7.03M
Depreciation and Depletion 7.42M7.99M-5.61M7.03M
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds 16.05M33.87M50.44M94M98.27M
Funds from Operations (12.78M)(155.75M)127.75M(190.98M)(220.69M)
Extraordinaries -----
Changes in Working Capital 62.89M2.92M(9.02M)(16.68M)(20.88M)
Receivables -----
Accounts Payable (526,000)1.03M(1.62M)3.71M2.27M
Other Assets/Liabilities 50.87M389,000(29.5M)(25.11M)(34.07M)
Net Operating Cash Flow 50.12M(152.83M)118.73M(207.65M)(241.57M)

Investing Activities

20182019202020212022 5-year trend
Capital Expenditures (3.39M)(17.92M)(3.1M)(8.5M)(17.83M)
Capital Expenditures (Fixed Assets) (3.39M)(17.92M)(3.1M)(8.5M)(17.83M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments (284.03M)165.63M(620.11M)(13.13M)(123.55M)
Purchase of Investments (557.93M)(369.7M)(1.29B)(1.42B)(1.12B)
Sale/Maturity of Investments 273.9M535.33M665.36M1.41B991.49M
Other Uses -----
Other Sources -----
Net Investing Cash Flow (287.42M)147.71M(623.21M)(21.63M)(141.39M)

Financing Activities

20182019202020212022 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 97.02M6.19M634.75M19.35M310.67M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 97.02M6.19M634.75M19.35M310.67M
Proceeds from Stock Options 93.02M-614.09M-296.22M
Other Proceeds from Sale of Stock 4M6.19M20.66M19.35M14.46M
Issuance/Reduction of Debt, Net -1.25M297.42M(3.74M)(3.15M)
Change in Current Debt -1.25M297.42M(3.74M)(3.15M)
Change in Long-Term Debt -----
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt -----
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 97.02M7.44M932.17M15.61M307.52M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash (140.29M)2.33M427.7M(213.67M)(75.43M)
Free Cash Flow 46.72M(170.75M)115.64M(216.15M)(259.4M)
Link to MarketWatch's Slice.